Safety and Efficacy of Hypofractionated Radiotherapy Combined with Tyrosine Kinase Inhibitors in Patients with Lung Metastases after Liver Transplantation for Hepatocellular Carcinoma

被引：0
|
作者：
Zhuang, Y. [1 ]
Chen, Y. [1 ]
Du, S. [2 ]
Hu, Y. [1 ]
Zeng, Z. C. [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2789
引用
收藏
页码：E360 / E360
页数：1
相关论文
共 50 条
  • [1] Safety and Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma
    Yang, Fei
    Yang, Jun
    Xiang, Wei
    Zhong, Bin-Yan
    Li, Wan-Ci
    Shen, Jian
    Zhang, Shuai
    Yin, Yu
    Sun, Hong-Peng
    Wang, Wan-Sheng
    Zhu, Xiao-Li
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [2] Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases
    Luo, Shuimei
    Chen, Long
    Chen, Xiuping
    Xie, Xianhe
    ONCOTARGET, 2015, 6 (18) : 16725 - 16734
  • [3] Safety and efficacy of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of patients with advanced unresectable hepatocellular carcinoma
    Li, Jinpeng
    Jia, Yuntao
    Han, Huihui
    Lin, Yanyan
    Song, Jinlong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Safety and efficacy of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of patients with advanced unresectable hepatocellular carcinoma
    Li, Jinpeng
    Kong, Mingxin
    Yu, Guangji
    Wang, Song
    Shi, Zhaozhang
    Han, Huihui
    Lin, Yanyan
    Shi, Jutian
    Song, Jinlong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation
    Bang, Kyunghye
    Casadei-Gardini, Andrea
    Yoo, Changhoon
    Iavarone, Massimo
    Ryu, Min-Hee
    Park, Sook Ryun
    Kim, Hyung-Don
    Yoon, Young-In
    Jung, Dong-Hwan
    Park, Gil-Chun
    Ahn, Chul-Soo
    Moon, Deok-Bog
    Hwang, Shin
    Kim, Ki-Hun
    Song, Gi-Won
    Mazzarelli, Chiara
    Alimenti, Eleonora
    Chan, Stephen L.
    De Giorgio, Massimo
    Ryoo, Baek-Yeol
    Lee, Sung-Gyu
    CANCER MEDICINE, 2023, 12 (03): : 2572 - 2579
  • [6] Significant Efficacy of Apatinib in a Patient With Hepatocellular Carcinoma Lung Metastases After Liver Transplantation: A Case Report
    Yu, Z.
    Liu, W.
    Deng, Y.
    Yao, J.
    Tang, H.
    Li, H.
    Yang, Y.
    Wang, G.
    Chen, G.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 4042 - 4045
  • [7] Efficacy and safety of switching other tyrosine kinase inhibitors to regorafenib combined with primary PD-1 antibodies in patients with hepatocellular carcinoma
    Pan, Shida
    Yu, Yingying
    Wang, Siyu
    Qiu, Qin
    Shen, Yingjuan
    Yang, Luo
    Liu, Xiaomeng
    Luan, Junqing
    Meng, Fanping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] The safety and efficacy of TACE combined with HAIC, PD-1 inhibitors, and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a retrospective study
    Huang, Zhongjing
    Wu, Ziyi
    Zhang, Lidong
    Yan, Likun
    Jiang, Hai
    Ai, Junhua
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation: A retrospective analysis
    Bang, Kyunghye
    Yoo, Changhoon
    Ryu, Min-Hee
    Park, Sook Ryun
    Kim, Hyung-Don
    Ryoo, Baek-Yeol
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [10] Evaluation of safety and efficacy of minocycline combined with tyrosine kinase inhibitors in patients of EGFR mutated metastatic lung cancer
    Thottian, A. G. F.
    Babu, G. K.
    Dasappa, L.
    Jacob, L. A.
    Babu, S. M.
    Lokesh, K. N.
    Rudresha, A. H.
    Saldanha, S.
    Gv, G.
    Lk, R.
    ANNALS OF ONCOLOGY, 2019, 30
12345